Table 4.
Outcome (%): | (a) Baseline SR / Discharge SR | (b) Baseline SR / Discharge AF | (c) Baseline AF / Discharge AF | p-value All Groups | p-value a vs. b | p-value a vs. c | p value b vs. c |
---|---|---|---|---|---|---|---|
Mortality | |||||||
- All cause | 15.8 | 35.7 | 29.9 | <0.0001 | <0.001 | <0.001 | 0.16 |
- Cardiovascular | 9.0 | 20.6 | 21.0 | <0.0001 | <0.001 | <0.001 | 0.91 |
Rehospitalization | 15.6 | 25.7 | 26.7 | <0.0001 | 0.01 | <0.001 | 0.84 |
Stroke/TIA | 6.3 | 10.3 | 9.0 | 0.19 | |||
Major Bleeding | 11.5 | 16.0 | 16.6 | 0.03 | 0.18 | 0.15 | 0.96 |
Major Vascular Event | 5.6 | 4.4 | 6.8 | 0.58 | |||
Renal Failure requiring dialysis | 2.7 | 7.3 | 4.6 | 0.005 | 0.002 | 0.03 | 0.22 |
New Pacemaker | 6.8 | 16.3 | 7.0 | 0.001 | 0.0004 | 0.96 | 0.002 |
LVEF | 60.0 [55.0,64.3] | 60.0 [55.0,65.0] | 55.6 [50.0,61.0] | 0.055 | |||
Change in 6MTWD (mean, in meters) | 33.1 | 8.0 | 38.3 | 0.32 | |||
On Aspirin | 86.6 | 71.4 | 72.3 | <0.0001 | 0.002 | <0.0001 | 0.89 |
On Clopidogrel | 32.9 | 27.3 | 16.3 | <0.0001 | 0.39 | <0.0001 | 0.055 |